Pulmonary vasoconstrictor action of KCNQ potassium channel blockers
2006

Effects of KCNQ Potassium Channel Blockers on Pulmonary Arteries

Sample size: 21 publication Evidence: high

Author Information

Author(s): Shreena Joshi, Prabhu Balan, Alison M Gurney

Primary Institution: University of Strathclyde and University of Manchester

Hypothesis

KCNQ channels may play a role in regulating the function of pulmonary arteries.

Conclusion

KCNQ channel blockers are potent constrictors of pulmonary arteries, acting directly on smooth muscle cells.

Supporting Evidence

  • Linopirdine and XE991 contracted rat and mouse pulmonary arteries significantly.
  • The maximum contraction was almost as large as the response to 50 mM K+.
  • Contraction was abolished in Ca2+-free solution, indicating a dependence on Ca2+ influx.

Takeaway

Two drugs, linopirdine and XE991, can make blood vessels in the lungs squeeze tighter, which might be important for understanding how to treat certain lung problems.

Methodology

The study measured the tension developed by rat and mouse pulmonary arteries using small vessel myography and tested the effects of KCNQ channel blockers.

Limitations

The study primarily focused on isolated arteries and may not fully represent in vivo conditions.

Participant Demographics

Male Sprague Dawley rats (250–300 g) and BALB/c mice (4–5 weeks old) were used.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1465-9921-7-31

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication